Lutathera (lutetium LU 177 dotatate) 3 doses decrease for close out
Ended Awarded Last action
- Contract number
- 36C25023F0658
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$78,521
Award facts
- Contract value 0% obligated
- $39,260.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10118, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$78,521 | |
| Original award | $117,781 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical products, received a delivery order award from Veterans Integrated Service Network (VISN) 10 on May 2, 2023, for three doses of LUTATHERA (lutetium Lu 177 dotatate) with a ceiling value of $39,260.35. The contract, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), carries a firm fixed-price structure with an ultimate completion date of October 31, 2023. The place of performance is New York, New York, and no small business set-aside was utilized for this award. This delivery order represents a task order call against one of the company's existing Blanket Purchase Agreements with VISN 10, valued at $6.9 million.
LUTATHERA is a targeted radioligand therapy product used in the treatment of neuroendocrine tumors and supports the Department of Veterans Affairs' nuclear medicine therapeutic capabilities across its healthcare system. The Department of Veterans Affairs has been the predominant federal customer for Advanced Accelerator Applications USA Inc.'s radiopharmaceutical portfolio, awarding numerous delivery orders and BPA calls across multiple VISNs nationwide. No subcontractors were identified on this award, indicating direct prime contractor supply of the pharmaceutical product to support patient care at VA medical facilities.
Quick answers
Who was awarded contract 36C25023F0658?
36C25023F0658 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on May 2, 2023.
How much is contract 36C25023F0658 worth?
The government has obligated -$78,521 on 36C25023F0658. Its current value, with exercised options, is $39,260.
Is contract 36C25023F0658 an order under another contract?
Yes. 36C25023F0658 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25023F0658 competed?
The extent of competition for 36C25023F0658 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award